Company news

Share this article:

Amgen said on Monday that 2,200 employees would lose their jobs under a company restructuring that includes about 675 layoffs at its headquarters in Thousand Oaks, CA, The Ventura County Star reported.

The total number of job cuts was close to what the company estimated when it announced in August that 2,200 to 2,600 job cuts were needed as part of a plan to reduce costs.  Amgen has seen decreased revenue during 2007 from its main anemia drug, Aranesp, after studies that raised safety concerns about anemia drugs and changes in how Medicare pays for them.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.